Products cost of revenue included the following charges arising from the acquisition of TomoTherapy during the three and twelve months ended June 30, 2012, respectively: $0 million and $8.3 million due to the write up of finished goods and work-in-process inventory on hand at the time of the acquisition from cost basis to fair value, $3.8 million and $15.3 million for amortization of intangible assets created by the acquisition, less than $0.1 million and $0.2 million due to employee severance and retention expenses and $0.1 and less than $(0.1) million charge and reduction in expense for property, plant and equipment revaluation.(D)
Services cost of revenue included the following charges and reductions to expenses arising from the acquisition of TomoTherapy during the three and twelve months ended June 30, 2012: $-0- and $3.6 million charge due to the write up of service related inventory on hand at the time of the acquisition from cost basis to fair value, $(0.4) million and $(3.5) million reductions in expenses due to the roll out of fair value increases in warranty and loss contracts reserves for the periods of service consumed, $0.1 million and $0.5 million charges for property, plant and equipment revaluation, less than $0.1 million and $1.9 million charges due to employee severance, integration and retention expenses and $(0.5) million and $(0.8) million of credits to reflect the cost of spare parts expected to be returned by TomoTherapy distributors who will cease servicing TomoTherapy systems once the integration is complete and Accuray personnel begin to provide service directly to these customers.Three months ended June 30,Years ended June 30,Gross Profit20122012201220112012201220122011GAAPAdjustmentsNon-GAAPPro forma Combined ResultsGAAPAdjustmentsNon-GAAPPro forma Combined ResultsProducts
$
28,015$
4,133$ 32,148$
43,396$
4,292$
25,937$
30,229$
55,113Services
8,527(631)7,896(806)32,119(8,410)23
'/>"/>
SOURCE Accuray Incorporated Copyright©2012 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Related medicine technology :1.
Accuray Incorporateds CEO to Speak at Morgan Stanley Global Healthcare Conference2.
Accuray to Acquire Morphormics, Inc.3.
Accuray and Erasmus Medical Center Sign Master Research and Collaboration Agreement4.
One Year After TomoTherapy Acquisition, Accuray on Track to Meet or Exceed Integration Success Metrics And Expecting Near-term Return to Profitability5.
Accuray Rolls Out Comprehensive Customer Service Program in Japan6.
Accuray Incorporated to Speak at Wells Fargo Healthcare Conference7.
Accuray Incorporated to Speak at Jefferies Global Healthcare Conference8.
Accuray and the German Cancer Research Center Sign Master Research and Collaboration Agreement9.
Accuray Appoints Richard Pettingill, LFACHE to Board of Directors10.
Accuray Announces Results for Third Quarter Fiscal 201211.
Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer